Effects of Angiotensin III on Protein,DNA,and Collagen Synthesis of Neonatal Cardiomyocytes and Cardiac Fibroblasts In Vitro

Abstract

This study compared angiotensin II (Ang II) and angiotensin III (Ang III) for their effects on rat neonatal cardiomyocytes and cardiac fibroblasts in vitro and discussed the possible role of Ang III in the pathogenesis of cardiac remodeling. To do so, protein synthesis, cardiac fibroblast proliferation, collagen synthesis, and secretion in response to treatment with Ang III and Ang II were investigated. Protein synthesis rate was assessed by ³H-Leucine (³H-Leu) incorporation; the content of DNA was defined by ³H-thymidine (³H-TdR) incorporation; and collagen synthesis and secretion were assessed by ³H-proline (³H-Pro) incorporation. In neonatal cardiomyocytes, Ang III stimulated protein synthesis in a concentration-dependent manner, whereas in neonatal cardiac fibroblasts, DNA synthesis as well as collagen synthesis and secretion were increased in a concentration-dependent manner. Treatment with captopril, selective aminopeptidase A (APA) inhibitor (EC33), or selective aminopeptidase N inhibitor (PC18) had no effect on these outcomes. Treatment with losartan significantly decreased the effects of Ang III, except for cardiomyocyte protein synthesis. Compared with Ang II, Ang III could stimulate cardiomyocyte protein synthesis, cardiac fibroblast proliferation, and collagen synthesis and secretion. Furthermore, 10^-7 mol/L Ang II but not Ang III significantly increased APA activity in both cardiomyocytes and fibroblasts. All these results show the bioactive effects of Ang III on myocardial cells and suggest that Ang III could be an important independent factor besides Ang II in the regulation of cardiac function and may affect the pathogenesis of cardiac remodeling.

Keywords

angiotensin cardiac remodeling angiotensin AT1 receptor angiotensin AT2 receptor aminopeptidase A

References

Paul M. , Poyan Mehr A. , Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86(3):747-803.

Carey RM , Siragy HM Newly recognized components of the rennin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev. 2003;24(3):261-271.

Warner FJ , Smith AI , Hooper NM , Turner AJ Angiotensin-converting enzyme-2: a molecular and cellular perspective. Cell Mol Life Sci. 2004;61(21):2704-2713.

Fedak PW , Verma S. , Weisel RD , Skrtic M. , Li RK Cardiac remodeling and failure from molecules to man. Cardiovasc Pathol. 2005;14(1):1-11.

Hoogwerf BJ Renin-angiotensin system blockade and cardiovascular and renal protection . Am J Cardiol. 2010;105(1 suppl): 30A-5A.

McCalmon SA , Desjardins DM , Ahmad S. , et al. Modulation of angiotensin II-mediated cardiac remodeling by the MEF2A target gene Xirp2. Circ Res. 2010 ;106(5):952-960.

Lijnen PJ , Petrov VV , Fagard RH. Angiotensin II-induced stimulation of collagen secretion and production in cardiac fibroblasts is mediated via angiotensin II subtype 1 receptors . J Renin Angiotensin Aldosterone Syst. 2001 ;2(2):117-122.

Lijnen PJ , Petrov VV , Fagard RH Induction of cardiac fibrosis by angiotensin II. Methods Find Exp Clin Pharmacol. 2000;22(10): 709-723.

Ruiz-Ortega M. , Lorenzo O. , Ruperez M. , et al. Role of the renin-angiotensin system in vascular diseases expanding the field. Hypertension. 2001;38(6):1382-1387.

10.

Campbell WB , Brooks SN , Pettinger WA Angiotensin II- and angiotensin 3-induced aldosterone release in vivo in the rat. Science. 1974;184(140):994-996.

11.

Ardaillou R. , Chansel D. Synthesis and effects of active fragments of angiotensin II. Kidney Int. 1997;52(6):1458-1468.

12.

Wright JW , Tamura-Meyers E. , Wilson WL , et al. Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats. Am J Physiol Regul Integr Comp Physiol. 2003;284(3):R725-R733.

13.

Gammelgaard I. , Wamberg S. , Bie P. Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system . Acta Physiol. 2006; 188(2):129-138.

14.

Zini S. , Fournie-Zaluski MC , Chauvel E. , Roques BP , Corvol P. , Llorens-Cortes C. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci. 1996;93(21):11968-11973.

15.

Simpson P. , Savion S. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Criss-striations, ultrastructure, and chronotropic response to isoproterenol. Circ Res. 1982;50(1):101-116.

16.

Ito H. , Miller SC , Billingham ME , et al. Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vitro and in vivo. Proc Natl Acad Sci USA . 1990;87(11):4275-4279.

17.

Yu SM , Tsai SY , Guh JH , Ko FN , Teng CM , Ou JT Mechanism of catecholamine induced proliferation of vascular smooth muscle cells. Circulation. 1996;94(3):547-554.

18.

Li YR Biochemistry of Extracellular Mesenchyma and Study Methods. 1sted. Beijing, China: People Health Publishing; 1988:222-223.

19.

Ino K. , Nagasaka T. , Okamoto T. , et al. Expression of aminopeptidase A in human gestational choriocarcinoma cell lines and tissues. Placenta. 2000;21(1):63-72.

20.

Bader M. , Peters J. , Baltatu O. , Müller DN , Luft FC , Ganten D. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J Mol Med. 2001; 79(2-3):76-102.

21.

Cockcroft JR , O’Kane KP , Webb DJ Tissue angiotensin generation and regulation of vascular tone. Pharmacol Ther. 1995;65(2): 193-213.

22.

Dzau VJ Tissue renin-angiotensin system in myocardial hypertrophy and failure. Arch Intern Med. 1993;153(8):937-942.

23.

Parmley WW Evolution of angiotensin-converting enzyme inhibition in hypertension, heart failure, and vascular protection. Am J Med. 1998;105(1A):27s-31s.

24.

Bodineau L. , Frugiere A. , Marc Y. , Claperon C. , Llorens-Cortes C. Aminopeptidase A inhibitors as centrally acting antihypertensive agents. Heart Fail Rev. 2008;13(3):311-319.

25.

Wilson WL , Roques BP , Llorens-Cartes C. , Speth RC , Harding JW , Wright JW Roles of brain angiotensins II and III in thirst and sodium appetite. Brain Res. 2005;1060(1-2): 108-117.

26.

Padia SH , Kemp BA , Howell NL , Fournie-Zaluski MC , Roques BP , Carey RM Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuesis in rats. Hypertension. 2008;51(2):460-465.

27.

Plovsing RR , Wamberg C. , Sandgaard NC , et al. Effects of truncated angiotensins in humans after double blockade of the renin system. Am J Physiol Regul Integr Comp Physiol . 2003;285(5): R981-R991.

28.

Wamberg C. , Plovsing RR , Sandgaard NC , Bie P. Effects of different angiotensins during acute, double blockade of the renin system in conscious dogs. Am J Physiol Regul Integr Comp Physiol . 2003;285(5):R971-R980.

29.

Dickstein GM , Woodson JF , Lamb NE , Rose CE Jr , Peach MJ , Carey RM Escape from the sodium-retaining action of intrarenal angiotensins II and III in the conscious dog. Endocrinology. 1985; 117(5):2160-2169.

30.

Fyhrquist F, Saijonmaa O. Renin-angiotensin system revisited. J Intern Med. 2008;264(3):224-236.

31.

Li L. , Wu Q. , Wang J. , Bucy RP , Cooper MD. Widespread tissue distribution of aminopeptidase A, an evolutionarily conserved ectoenzyme recognized by the BP-1 antibody. Tissue Antigens. 1993;42(5):488-496.

32.

De Gasparo M. , Catt KJ , Inaqami T. , Wright JW , Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000;52(3):415-472.

33.

Marrero MB , Schieffer B. , Paxton WG , et al. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature. 1995;375(6528):247-250.

34.

Schieffer B. , Drexler H. , Ling BN , Marrero MB G protein coupled receptors control vascular smooth muscle cell proliferation via pp60c-src and p21ras. Am J Physiol Cell Physiol. 1997;272(6 pt 1):C2019-C2030.

35.

Unger T. , Chung O. , Csikos T. , et al. Angiotensin receptors. J Hypertens Suppl. 1996;14(5):S95-S103.

36.

Pinto YM , Pinto-Sietsma SJ , Philipp T. , et al. Reduction in left ventricular messenger RNA for transforming growth factor beta(1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 Rat. Hypertension. 2000;36(5):747-754.

37.

Sun Y. , Ramires FJ , Zhou G. , Ganjam VK , Weber KT Fibrous tissue and angiotensin II. J Mol Cell Cardiol. 1997;29(8):2001-2012.

38.

Ruiz-Orteqa M. , Lorenzo O. , Eqido J. Angiotensin III upregulated genes involved in kidney damage in cultured mesangial cells and renal interstitial fibroblast . Kidney Int Suppl. 1998;54(68):S41-S45.

39.

Carcia-Sainz JA , Garcia-Caballero A. , Gonzalez-Cspinosa C. Angiotensin AT1 receptors in clone 9 rat liver cells: Ca2+ signaling and c-fos expression . Eur J pharmacol. 1998;362(2-3):235-243.

40.

Catalioto RM , Renzetti AR , Criscuoli M. , Morbidelli L. , Subissi A. Role of calcium in angiotensin II-induced prostanglandin release and DNA synthesis in rat vascular smooth muscle cells . J Cardiovasc Pharmacol. 1996;27(2):195-200.